– Excellence by Choice
Fredag 16 oktober bjuder Umeå universitet in till Jubileumssymposiet Excellence by Choice. Deltagare är bland andra Emmanuelle Charpentier, som genom upptäckten av CRISPR-Cas9-enzymets mekanism ligger bakom ett biomedicinskt forskningsgenombrott.
“What enables groundbreaking research? What might attract the next generation of researchers? These questions are of fundamental importance to research and will be highlighted and discussed at the symposium Excellence by Choice.
Invited speakers include internationally leading scientists and research directors involved in recruitment and scientific policy guiding. Young group leader colleagues share their experience together with the successful MIMS group leader and role model Emmanuelle Charpentier, now known worldwide for her research on CRISPR-Cas9, a groundbreaking genome editing tool.
The symposium is organised by Umeå University and its Laboratory for Molecular Infection Medicine Sweden – MIMS – the Swedish node in The Nordic EMBL Partnership for Molecular Medicine.
The symposium will be held in English.
Programme – 13:30–16:30 in Aula Nordica
Moderator: Anna Nilsson Vindefjärd, PhD MBA, Secretary General, Research!Sweden.
Welcome: Lena Gustafsson, Professor, Vice-Chancellor Umeå University.
Excellence by Choice for scientific renewal at EMBL and our partnerships
Iain Mattaj, Professor, Director General EMBL, The European Molecular Biology Laboratory, Heidelberg, Germany.
The Global Challenge of infections: A research area of continued excellence at Umeå University
Jörg Hacker, Professor, President, German National Academy of Sciences Leopoldina, Germany.
Just joined Umeå University: A Choice made by both me and MIMS
Andrea Puhar, PhD, Group Leader MIMS, The Laboratory for Molecular Infection Medicine Sweden, Umeå University.
14:30 – Break
The Umeå University EC Jubilee Award 2015: ”The MIMS Excellence by Choice Programme”
Lena Gustafsson, Professor, Vice-Chancellor Umeå University.
From Asilomar to Umeå: From gene cloning to genome editing
Ernst-Ludwig Winnacker, Professor, Gene Center, Ludwig Maximilian University, Munich, Germany.
The CRISPR-Cas9 revolutionary genome engineering technology: Lessons from bacteria
Emmanuelle Charpentier, Professor, Max Planck Institute for Infection Biology Berlin, Germany, Helmholtz Centre for Infection Research, Hannover Medical School, Germany, Visiting Professor and Group Leader MIMS, Umeå University.
CRISPR-Cas9: An excellent tool for our leukemia research
Dirk Heckl, Assistant Professor, Junior Research Group Leader, Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany.
16:00 – Panel Discussion
Emmanuelle Charpentier, Professor. Andrea Puhar, PhD. Anna Överby Wernstedt, Associate Professor, Group Leader MIMS, Umeå University. Ernst-Ludwig Winnacker, Professor. Bernt Eric Uhlin, Professor, Director MIMS, Umeå University.